Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis

被引:7
作者
Matsunami, Tokio [1 ]
Sato, Yukita [1 ]
Ariga, Satomi [1 ]
Sato, Takuya [1 ]
Kashimura, Haruka [1 ]
Hasegawa, Yuki [1 ]
Yukawa, Masayoshi [1 ]
机构
[1] Nihon Univ, Lab Biomed Sci, Dept Vet Med, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan
关键词
Nonalcoholic steatohepatitis; adiponectin receptor 2; inflammation; oxidative stress; Zucker rats; FATTY LIVER; REAL-TIME; INSULIN; PROTEIN; PROGRESSION; EXPRESSION; DISEASE; ASSAY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The pathogenesis of nonalcoholic steatohepatitis (NASH) is not well understood; however, the progression of fatty liver to NASH has been linked to oxidative stress and lipid peroxidation in the liver, leading to inflammation. Although the adiponectin receptor 2 (AdipoR2) has been identified as a modulator of oxidative stress and inflammation in the liver, it remains unclear whether the receptor has hepatic antioxidant and anti-inflammatory effects in NASH. In this study, we used an animal model of NASH to examine hepatic AdipoR2. Obese fa/fa Zucker rats fed a high-fat and high-cholesterol (HFC) diet spontaneously developed fatty liver with inflammation and fibrosis, characteristic of NASH, after 4, 8, or 12 weeks of HFC diet consumption. AdipoR2 expression was significantly decreased, whereas the expression of genes related to NADPH oxidase complex were increased. As a result of the decrease in AdipoR2 expression, the mRNA expression of genes located downstream of AdipoR2, i.e., Cu-Zn superoxide dismutase (Cu-Zn SOD) and Mn-SOD, also decreased. Furthermore, the expression of genes related to inflammation was increased. Increased oxidative stress and inflammation by down-regulation of AdipoR2 may contribute to the progression of NASH. Thus, the AdipoR2 might be a crucially important regulator of hepatic oxidative stress and inflammation in NASH.
引用
收藏
页码:472 / 481
页数:10
相关论文
共 28 条
[1]
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]
NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[3]
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[4]
Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[5]
Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
[6]
A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats [J].
Carmiel-Haggai, M ;
Cederbaum, AI ;
Nieto, N .
FASEB JOURNAL, 2004, 18 (14) :136-+
[7]
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis [J].
Feldstein, AE ;
Canbay, A ;
Angulo, P ;
Taniai, M ;
Burgart, LJ ;
Lindor, KD ;
Gores, GJ .
GASTROENTEROLOGY, 2003, 125 (02) :437-443
[8]
Ascorbic acid concentrations in dimethylnitrosamine-induced hepatic fibrosis in rats [J].
George, J .
CLINICA CHIMICA ACTA, 2003, 335 (1-2) :39-47
[9]
Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance [J].
James, OFW ;
Day, CP .
JOURNAL OF HEPATOLOGY, 1998, 29 (03) :495-501
[10]
Adiponectin and adiponectin receptors [J].
Kadowaki, T ;
Yamauchi, T .
ENDOCRINE REVIEWS, 2005, 26 (03) :439-451